COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
Sahar Memar Montazerin (talk | contribs)
No edit summary
Sahar Memar Montazerin (talk | contribs)
No edit summary
Line 19: Line 19:
*[[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]]
*[[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]]
*Sara Haddadi
*Sara Haddadi
*[[User:Sara Mohsin|Sara Mohsin, M.B.B.S.]]
*[[User:Sogand Goudarzi|Sogand Goudarzi, M.D.]]
*[[User:Sogand Goudarzi|Sogand Goudarzi, M.D.]]
*Zaida Obeidat
*Zaida Obeidat

Revision as of 17:54, 8 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief: